Results 211 to 220 of about 102,686 (380)

The association of umbilical cord blood neurofilament light with non‐reassuring fetal status: A prospective observational study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Early detection of hypoxic–ischemic encephalopathy (HIE) in neonates is critical. We conducted a pilot cohort study to determine the feasibility of collecting umbilical cord blood samples for neurofilament light (NfL) and to assess the association of NfL with non‐reassuring fetal status and other cord biomarkers. We aimed to address (
David Zalcberg   +17 more
wiley   +1 more source

Domain unfolding in neurofilament sidearms: effects of phosphorylation and ATP [PDF]

open access: bronze, 2002
Helim Aranda‐Espinoza   +4 more
openalex   +1 more source

Author Correction: The potential of neurofilaments analysis using dry-blood and plasma spots [PDF]

open access: gold, 2020
Vittoria Lombardi   +5 more
openalex   +1 more source

Evaluating the Role of α‐Synuclein Seed Amplification as a Disease Progression Marker: Evidence and Uncertainties

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background α‐synuclein seeding amplification assay (α‐synuclein SAA) development as a diagnostic biomarker for Parkinson's disease (PD) has shown promising results over the past decade. However, the utility of these assays in the prediction of disease progression is unclear.
Daniel Belete   +5 more
wiley   +1 more source

Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Huntington's disease (HD) is characterized by early, selective, progressive vulnerability of striatal medium spiny neurons (MSNs). Proenkephalin (PENK), a precursor of opioid peptides abundantly expressed in MSNs, is a promising biomarker of striatal integrity, but region‐specific associations and its potential for early‐stage ...
Mena Farag   +14 more
wiley   +1 more source

Interplay Between Sex and Cytosine‐Adenine‐Guanine‐Age Product Score in Huntington's Disease: Clinical and Neuroimaging Perspectives

open access: yesMovement Disorders, EarlyView.
Abstract Background Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a cytosine‐adenine‐guanine (CAG) repeat expansion in the huntingtin gene. The disease exhibits sex‐related differences in symptomatology and disease progression, but the effect on brain structural biomarkers and the interaction between sex and CAG‐age ...
Jingwen Yao   +10 more
wiley   +1 more source

A Biomarker‐Based Classification of Corticobasal Syndrome

open access: yesMovement Disorders, EarlyView.
Abstract Background Corticobasal syndrome (CBS) is a clinically defined syndrome with progressive movement and cortical dysfunction, caused by various underlying pathologies, most commonly tau‐predominant pathologies such as progressive supranuclear palsy and corticobasal degeneration, or Alzheimer's disease (AD).
Carla Palleis   +13 more
wiley   +1 more source

Longitudinal Blood‐Biomarker‐Based Assessment of Brain Injury in Patients Undergoing Deep Brain Stimulation and Magnetic Resonance–Guided Focused Ultrasound

open access: yesMovement Disorders, EarlyView.
Abstract Background Deep brain stimulation (DBS) and magnetic resonance–guided focused ultrasound (MRgFUS) are associated with neuroaxonal damage and astroglial activation; yet their extent and timing remain unclear despite clinical relevance for monitoring and outcome assessment.
Justina Dargvainiene   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy